{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:48:38Z","timestamp":1791287318304,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00262-022-03353-8","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T04:07:35Z","timestamp":1674446855000},"page":"1823-1834","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Preventive effect of tertiary lymphoid structures on lymph node metastasis of lung adenocarcinoma"],"prefix":"10.1007","volume":"72","author":[{"given":"Sho","family":"Wakasu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4456-429X","authenticated-orcid":false,"given":"Tetsuzo","family":"Tagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Haratake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Oku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyoshi","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinao","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mototsugu","family":"Shimokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,23]]},"reference":[{"issue":"19","key":"3353_CR1","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","volume":"375","author":"M Reck","year":"2016","unstructured":"Reck M, Rodriguez-Abreu D, Robinson AG, Hui R, Csoszi T, Fulop A, Gottfried M, Peled N, Tafreshi A, Cuffe S, O\u2019Brien M, Rao S, Hotta K, Leiby MA, Lubiniecki GM, Shentu Y, Rangwala R, Brahmer JR, Investigators K (2016) Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. N Engl J Med 375(19):1823\u20131833. https:\/\/doi.org\/10.1056\/NEJMoa1606774","journal-title":"N Engl J Med"},{"issue":"22","key":"3353_CR2","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","volume":"378","author":"L Gandhi","year":"2018","unstructured":"Gandhi L, Rodriguez-Abreu D, Gadgeel S, Esteban E, Felip E, De Angelis F, Domine M, Clingan P, Hochmair MJ, Powell SF, Cheng SY, Bischoff HG, Peled N, Grossi F, Jennens RR, Reck M, Hui R, Garon EB, Boyer M, Rubio-Viqueira B, Novello S, Kurata T, Gray JE, Vida J, Wei Z, Yang J, Raftopoulos H, Pietanza MC, Garassino MC, Investigators K (2018) Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer. N Engl J Med 378(22):2078\u20132092. https:\/\/doi.org\/10.1056\/NEJMoa1801005","journal-title":"N Engl J Med"},{"issue":"7791","key":"3353_CR3","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/d41586-019-03943-0","volume":"577","author":"TC Bruno","year":"2020","unstructured":"Bruno TC (2020) New predictors for immunotherapy responses sharpen our view of the tumour microenvironment. Nature 577(7791):474\u2013476. https:\/\/doi.org\/10.1038\/d41586-019-03943-0","journal-title":"Nature"},{"issue":"11","key":"3353_CR4","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.it.2014.09.006","volume":"35","author":"MC Dieu-Nosjean","year":"2014","unstructured":"Dieu-Nosjean MC, Goc J, Giraldo NA, Sautes-Fridman C, Fridman WH (2014) Tertiary lymphoid structures in cancer and beyond. Trends Immunol 35(11):571\u2013580. https:\/\/doi.org\/10.1016\/j.it.2014.09.006","journal-title":"Trends Immunol"},{"issue":"27","key":"3353_CR5","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1200\/JCO.2007.15.0284","volume":"26","author":"MC Dieu-Nosjean","year":"2008","unstructured":"Dieu-Nosjean MC, Antoine M, Danel C, Heudes D, Wislez M, Poulot V, Rabbe N, Laurans L, Tartour E, de Chaisemartin L, Lebecque S, Fridman WH, Cadranel J (2008) Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol 26(27):4410\u20134417. https:\/\/doi.org\/10.1200\/JCO.2007.15.0284","journal-title":"J Clin Oncol"},{"key":"3353_CR6","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.3389\/fimmu.2017.01830","volume":"8","author":"EJ Colbeck","year":"2017","unstructured":"Colbeck EJ, Ager A, Gallimore A, Jones GW (2017) Tertiary lymphoid structures in cancer: drivers of antitumor immunity, immunosuppression, or bystander sentinels in Disease? Front Immunol 8:1830. https:\/\/doi.org\/10.3389\/fimmu.2017.01830","journal-title":"Front Immunol"},{"key":"3353_CR7","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.91487","author":"C Gu-Trantien","year":"2017","unstructured":"Gu-Trantien C, Migliori E, Buisseret L, de Wind A, Brohee S, Garaud S, Noel G, Dang Chi VL, Lodewyckx JN, Naveaux C, Duvillier H, Goriely S, Larsimont D, Willard-Gallo K (2017) CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.91487","journal-title":"JCI Insight"},{"issue":"27","key":"3353_CR8","doi-asserted-by":"publisher","first-page":"13490","DOI":"10.1073\/pnas.1905301116","volume":"116","author":"S Nayar","year":"2019","unstructured":"Nayar S, Campos J, Smith CG, Iannizzotto V, Gardner DH, Mourcin F, Roulois D, Turner J, Sylvestre M, Asam S, Glaysher B, Bowman SJ, Fearon DT, Filer A, Tarte K, Luther SA, Fisher BA, Buckley CD, Coles MC, Barone F (2019) Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology. Proc Natl Acad Sci U S A 116(27):13490\u201313497. https:\/\/doi.org\/10.1073\/pnas.1905301116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3353_CR9","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.3389\/fimmu.2019.01398","volume":"10","author":"L Lin","year":"2019","unstructured":"Lin L, Hu X, Zhang H, Hu H (2019) Tertiary lymphoid organs in cancer immunology: mechanisms and the new strategy for immunotherapy. Front Immunol 10:1398. https:\/\/doi.org\/10.3389\/fimmu.2019.01398","journal-title":"Front Immunol"},{"issue":"2","key":"3353_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/JLB.3MR0218-062R","volume":"104","author":"A Nerviani","year":"2018","unstructured":"Nerviani A, Pitzalis C (2018) Role of chemokines in ectopic lymphoid structures formation in autoimmunity and cancer. J Leukoc Biol 104(2):333\u2013341. https:\/\/doi.org\/10.1002\/JLB.3MR0218-062R","journal-title":"J Leukoc Biol"},{"issue":"7","key":"3353_CR11","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1164\/rccm.201309-1611OC","volume":"189","author":"C Germain","year":"2014","unstructured":"Germain C, Gnjatic S, Tamzalit F, Knockaert S, Remark R, Goc J, Lepelley A, Becht E, Katsahian S, Bizouard G, Validire P, Damotte D, Alifano M, Magdeleinat P, Cremer I, Teillaud JL, Fridman WH, Sautes-Fridman C, Dieu-Nosjean MC (2014) Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer. Am J Respir Crit Care Med 189(7):832\u2013844. https:\/\/doi.org\/10.1164\/rccm.201309-1611OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"3353_CR12","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1038\/bjc.2015.145","volume":"112","author":"N Hiraoka","year":"2015","unstructured":"Hiraoka N, Ino Y, Yamazaki-Itoh R, Kanai Y, Kosuge T, Shimada K (2015) Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer. Br J Cancer 112(11):1782\u20131790. https:\/\/doi.org\/10.1038\/bjc.2015.145","journal-title":"Br J Cancer"},{"issue":"4","key":"3353_CR13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3233\/BLC-170120","volume":"3","author":"M Koti","year":"2017","unstructured":"Koti M, Xu AS, Ren KYM, Visram K, Ren R, Berman DM, Siemens DR (2017) Tertiary lymphoid structures associate with tumour stage in urothelial bladder cancer. Bladder Cancer 3(4):259\u2013267. https:\/\/doi.org\/10.3233\/BLC-170120","journal-title":"Bladder Cancer"},{"issue":"2","key":"3353_CR14","doi-asserted-by":"publisher","first-page":"e1378844","DOI":"10.1080\/2162402X.2017.1378844","volume":"7","author":"F Posch","year":"2018","unstructured":"Posch F, Silina K, Leibl S, Mundlein A, Moch H, Siebenhuner A, Samaras P, Riedl J, Stotz M, Szkandera J, Stoger H, Pichler M, Stupp R, van den Broek M, Schraml P, Gerger A, Petrausch U, Winder T (2018) Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer. Oncoimmunology 7(2):e1378844. https:\/\/doi.org\/10.1080\/2162402X.2017.1378844","journal-title":"Oncoimmunology"},{"issue":"7791","key":"3353_CR15","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","volume":"577","author":"BA Helmink","year":"2020","unstructured":"Helmink BA, Reddy SM, Gao J, Zhang S, Basar R, Thakur R, Yizhak K, Sade-Feldman M, Blando J, Han G, Gopalakrishnan V, Xi Y, Zhao H, Amaria RN, Tawbi HA, Cogdill AP, Liu W, LeBleu VS, Kugeratski FG, Patel S, Davies MA, Hwu P, Lee JE, Gershenwald JE, Lucci A, Arora R, Woodman S, Keung EZ, Gaudreau PO, Reuben A, Spencer CN, Burton EM, Haydu LE, Lazar AJ, Zapassodi R, Hudgens CW, Ledesma DA, Ong S, Bailey M, Warren S, Rao D, Krijgsman O, Rozeman EA, Peeper D, Blank CU, Schumacher TN, Butterfield LH, Zelazowska MA, McBride KM, Kalluri R, Allison J, Petitprez F, Fridman WH, Sautes-Fridman C, Hacohen N, Rezvani K, Sharma P, Tetzlaff MT, Wang L, Wargo JA (2020) B cells and tertiary lymphoid structures promote immunotherapy response. Nature 577(7791):549\u2013555. https:\/\/doi.org\/10.1038\/s41586-019-1922-8","journal-title":"Nature"},{"issue":"7791","key":"3353_CR16","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","volume":"577","author":"R Cabrita","year":"2020","unstructured":"Cabrita R, Lauss M, Sanna A, Donia M, Skaarup Larsen M, Mitra S, Johansson I, Phung B, Harbst K, Vallon-Christersson J, van Schoiack A, Lovgren K, Warren S, Jirstrom K, Olsson H, Pietras K, Ingvar C, Isaksson K, Schadendorf D, Schmidt H, Bastholt L, Carneiro A, Wargo JA, Svane IM, Jonsson G (2020) Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature 577(7791):561\u2013565. https:\/\/doi.org\/10.1038\/s41586-019-1914-8","journal-title":"Nature"},{"issue":"7791","key":"3353_CR17","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","volume":"577","author":"F Petitprez","year":"2020","unstructured":"Petitprez F, de Reynies A, Keung EZ, Chen TW, Sun CM, Calderaro J, Jeng YM, Hsiao LP, Lacroix L, Bougouin A, Moreira M, Lacroix G, Natario I, Adam J, Lucchesi C, Laizet YH, Toulmonde M, Burgess MA, Bolejack V, Reinke D, Wani KM, Wang WL, Lazar AJ, Roland CL, Wargo JA, Italiano A, Sautes-Fridman C, Tawbi HA, Fridman WH (2020) B cells are associated with survival and immunotherapy response in sarcoma. Nature 577(7791):556\u2013560. https:\/\/doi.org\/10.1038\/s41586-019-1906-8","journal-title":"Nature"},{"issue":"8","key":"3353_CR18","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1093\/annonc\/mdy218","volume":"29","author":"TR Cottrell","year":"2018","unstructured":"Cottrell TR, Thompson ED, Forde PM, Stein JE, Duffield AS, Anagnostou V, Rekhtman N, Anders RA, Cuda JD, Illei PB, Gabrielson E, Askin FB, Niknafs N, Smith KN, Velez MJ, Sauter JL, Isbell JM, Jones DR, Battafarano RJ, Yang SC, Danilova L, Wolchok JD, Topalian SL, Velculescu VE, Pardoll DM, Brahmer JR, Hellmann MD, Chaft JE, Cimino-Mathews A, Taube JM (2018) Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC). Ann Oncol 29(8):1853\u20131860. https:\/\/doi.org\/10.1093\/annonc\/mdy218","journal-title":"Ann Oncol"},{"issue":"6","key":"3353_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","volume":"19","author":"C Sautes-Fridman","year":"2019","unstructured":"Sautes-Fridman C, Petitprez F, Calderaro J, Fridman WH (2019) Tertiary lymphoid structures in the era of cancer immunotherapy. Nat Rev Cancer 19(6):307\u2013325. https:\/\/doi.org\/10.1038\/s41568-019-0144-6","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"3353_CR20","doi-asserted-by":"publisher","first-page":"E761","DOI":"10.1073\/pnas.1620433114","volume":"114","author":"K Chamoto","year":"2017","unstructured":"Chamoto K, Chowdhury PS, Kumar A, Sonomura K, Matsuda F, Fagarasan S, Honjo T (2017) Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity. Proc Natl Acad Sci U S A 114(5):E761\u2013E770. https:\/\/doi.org\/10.1073\/pnas.1620433114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"3353_CR21","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.jtho.2016.06.006","volume":"11","author":"K Takada","year":"2016","unstructured":"Takada K, Okamoto T, Shoji F, Shimokawa M, Akamine T, Takamori S, Katsura M, Suzuki Y, Fujishita T, Toyokawa G, Morodomi Y, Okano S, Oda Y, Maehara Y (2016) Clinical significance of PD-L1 protein expression in surgically resected primary lung adenocarcinoma. J Thorac Oncol 11(11):1879\u20131890. https:\/\/doi.org\/10.1016\/j.jtho.2016.06.006","journal-title":"J Thorac Oncol"},{"key":"3353_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12885-015-1116-1","volume":"15","author":"SL Figenschau","year":"2015","unstructured":"Figenschau SL, Fismen S, Fenton KA, Fenton C, Mortensen ES (2015) Tertiary lymphoid structures are associated with higher tumor grade in primary operable breast cancer patients. BMC Cancer 15:101. https:\/\/doi.org\/10.1186\/s12885-015-1116-1","journal-title":"BMC Cancer"},{"issue":"10","key":"3353_CR23","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.3889\/oamjms.2018.341","volume":"6","author":"G Trajkovski","year":"2018","unstructured":"Trajkovski G, Ognjenovic L, Karadzov Z, Jota G, Hadzi-Manchev D, Kostovski O, Volcevski G, Trajkovska V, Nikolova D, Spasevska L, Janevska V, Janevski V (2018) Tertiary lymphoid structures in colorectal cancers and their prognostic value. Open Access Maced J Med Sci 6(10):1824\u20131828. https:\/\/doi.org\/10.3889\/oamjms.2018.341","journal-title":"Open Access Maced J Med Sci"},{"key":"3353_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.09.001","author":"F Dammeijer","year":"2020","unstructured":"Dammeijer F, van Gulijk M, Mulder EE, Lukkes M, Klaase L, van den Bosch T, van Nimwegen M, Lau SP, Latupeirissa K, Schetters S, van Kooyk Y, Boon L, Moyaart A, Mueller YM, Katsikis PD, Eggermont AM, Vroman H, Stadhouders R, Hendriks RW, Thusen JV, Grunhagen DJ, Verhoef C, van Hall T, Aerts JG (2020) The PD-1\/PD-L1-checkpoint restrains T cell Immunity in tumor-draining lymph nodes. Cancer Cell. https:\/\/doi.org\/10.1016\/j.ccell.2020.09.001","journal-title":"Cancer Cell"},{"issue":"2","key":"3353_CR25","doi-asserted-by":"publisher","first-page":"432","DOI":"10.4049\/jimmunol.1701269","volume":"200","author":"VH Engelhard","year":"2018","unstructured":"Engelhard VH, Rodriguez AB, Mauldin IS, Woods AN, Peske JD, Slingluff CL Jr (2018) Immune cell infiltration and Tertiary lymphoid structures as determinants of antitumor immunity. J Immunol 200(2):432\u2013442. https:\/\/doi.org\/10.4049\/jimmunol.1701269","journal-title":"J Immunol"},{"key":"3353_CR26","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3389\/fimmu.2016.00414","volume":"7","author":"S Pesce","year":"2016","unstructured":"Pesce S, Moretta L, Moretta A, Marcenaro E (2016) Human NK cell subsets redistribution in pathological conditions: a role for CCR7 receptor. Front Immunol 7:414. https:\/\/doi.org\/10.3389\/fimmu.2016.00414","journal-title":"Front Immunol"},{"issue":"20","key":"3353_CR27","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1158\/0008-5472.CAN-11-0952","volume":"71","author":"L de Chaisemartin","year":"2011","unstructured":"de Chaisemartin L, Goc J, Damotte D, Validire P, Magdeleinat P, Alifano M, Cremer I, Fridman WH, Sautes-Fridman C, Dieu-Nosjean MC (2011) Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer. Cancer Res 71(20):6391\u20136399. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-0952","journal-title":"Cancer Res"},{"issue":"3","key":"3353_CR28","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/cvr\/cvt263","volume":"101","author":"K Guedj","year":"2014","unstructured":"Guedj K, Khallou-Laschet J, Clement M, Morvan M, Gaston AT, Fornasa G, Dai J, Gervais-Taurel M, Eberl G, Michel JB, Caligiuri G, Nicoletti A (2014) M1 macrophages act as LTbetaR-independent lymphoid tissue inducer cells during atherosclerosis-related lymphoid neogenesis. Cardiovasc Res 101(3):434\u2013443. https:\/\/doi.org\/10.1093\/cvr\/cvt263","journal-title":"Cardiovasc Res"},{"key":"3353_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3389\/fimmu.2015.00067","volume":"6","author":"C Germain","year":"2015","unstructured":"Germain C, Gnjatic S, Dieu-Nosjean MC (2015) Tertiary lymphoid structure-associated B cells are key players in anti-tumor immunity. Front Immunol 6:67. https:\/\/doi.org\/10.3389\/fimmu.2015.00067","journal-title":"Front Immunol"},{"issue":"3","key":"3353_CR30","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1158\/0008-5472.CAN-13-1342","volume":"74","author":"J Goc","year":"2014","unstructured":"Goc J, Germain C, Vo-Bourgais TK, Lupo A, Klein C, Knockaert S, de Chaisemartin L, Ouakrim H, Becht E, Alifano M, Validire P, Remark R, Hammond SA, Cremer I, Damotte D, Fridman WH, Sautes-Fridman C, Dieu-Nosjean MC (2014) Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells. Cancer Res 74(3):705\u2013715. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-1342","journal-title":"Cancer Res"},{"issue":"12","key":"3353_CR31","doi-asserted-by":"publisher","first-page":"13765","DOI":"10.18632\/oncotarget.7282","volume":"7","author":"DQ Zeng","year":"2016","unstructured":"Zeng DQ, Yu YF, Ou QY, Li XY, Zhong RZ, Xie CM, Hu QG (2016) Prognostic and predictive value of tumor-infiltrating lymphocytes for clinical therapeutic research in patients with non-small cell lung cancer. Oncotarget 7(12):13765\u201313781. https:\/\/doi.org\/10.18632\/oncotarget.7282","journal-title":"Oncotarget"},{"issue":"5","key":"3353_CR32","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1158\/0008-5472.CAN-17-1987","volume":"78","author":"K Silina","year":"2018","unstructured":"Silina K, Soltermann A, Attar FM, Casanova R, Uckeley ZM, Thut H, Wandres M, Isajevs S, Cheng P, Curioni-Fontecedro A, Foukas P, Levesque MP, Moch H, Line A, van den Broek M (2018) Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma. Cancer Res 78(5):1308\u20131320. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-1987","journal-title":"Cancer Res"},{"key":"3353_CR33","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.3389\/fimmu.2017.01412","volume":"8","author":"C Solinas","year":"2017","unstructured":"Solinas C, Garaud S, De Silva P, Boisson A, Van den Eynden G, de Wind A, Risso P, Rodrigues Vitoria J, Richard F, Migliori E, Noel G, Duvillier H, Craciun L, Veys I, Awada A, Detours V, Larsimont D, Piccart-Gebhart M, Willard-Gallo K (2017) Immune checkpoint molecules on tumor-infiltrating lymphocytes and their association with tertiary lymphoid structures in human breast cancer. Front Immunol 8:1412. https:\/\/doi.org\/10.3389\/fimmu.2017.01412","journal-title":"Front Immunol"},{"issue":"6","key":"3353_CR34","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/gb-2005-6-6-223","volume":"6","author":"M Collins","year":"2005","unstructured":"Collins M, Ling V, Carreno BM (2005) The B7 family of immune-regulatory ligands. Genome Biol 6(6):223. https:\/\/doi.org\/10.1186\/gb-2005-6-6-223","journal-title":"Genome Biol"},{"issue":"1","key":"3353_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/cei.12392","volume":"178","author":"G Hodge","year":"2014","unstructured":"Hodge G, Barnawi J, Jurisevic C, Moffat D, Holmes M, Reynolds PN, Jersmann H, Hodge S (2014) Lung cancer is associated with decreased expression of perforin, granzyme B and interferon (IFN)-gamma by infiltrating lung tissue T cells, natural killer (NK) T-like and NK cells. Clin Exp Immunol 178(1):79\u201385. https:\/\/doi.org\/10.1111\/cei.12392","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"3353_CR36","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/ni.3836","volume":"18","author":"A Johansson-Percival","year":"2017","unstructured":"Johansson-Percival A, He B, Li ZJ, Kjellen A, Russell K, Li J, Larma I, Ganss R (2017) De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors. Nat Immunol 18(11):1207\u20131217. https:\/\/doi.org\/10.1038\/ni.3836","journal-title":"Nat Immunol"},{"issue":"4","key":"3353_CR37","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1183\/09031936.00134910","volume":"38","author":"C Martin","year":"2011","unstructured":"Martin C, Thevenot G, Danel S, Chapron J, Tazi A, Macey J, Dusser DJ, Fajac I, Burgel PR (2011) Pseudomonas aeruginosa induces vascular endothelial growth factor synthesis in airway epithelium in vitro and in vivo. Eur Respir J 38(4):939\u2013946. https:\/\/doi.org\/10.1183\/09031936.00134910","journal-title":"Eur Respir J"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-022-03353-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-022-03353-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-022-03353-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T11:06:27Z","timestamp":1684494387000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-022-03353-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["3353"],"URL":"https:\/\/doi.org\/10.1007\/s00262-022-03353-8","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,23]]},"assertion":[{"value":"13 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was approved by our Institutional Review Board (Kyushu University, IRB No. 2019\u2013232).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}